We’ll help you find the right home for your research – fast With over 50 journals, including The Lancet Oncology, Cancer Cell, European Journal of Cancer and Cancer Letters, Elsevier’s Oncology Journal Network has the right fit for your paper. ...
Gentry, Sharon S.Journal of Oncology Navigation & Survivorship
In a conversation during the 2022 American Society of Hematology Annual Meeting, an expert from the University of Texas MD Anderson Cancer Center, spoke to how treatments have improved for patients with mantle cell lymphoma. Momelotinib May Become ‘No. 1 Choice’ for Second-Line Therapy in My...
Lung cancer is the second most common cancer and the leading cause of cancer deaths in the United States, according to the American Cancer Society. In an interview with CBS News, Dr. Karen Knudsen, CEO of the American Cancer Society, said this trend could be reversed through prevention and ...
According to their website, for the last 100 years, the American Cancer Society has been “on a mission to free the world from cancer.” However, its eugenics origin, as well as the focus of its current leadership, suggest something quite different. More to the point is the fact that th...
In: Proceedings of the American Association for Cancer Research Annual Meeting 2023; Part 1 (Regular and Invited Abstracts); 2023 Apr 14-19; Orlando, ... Lawrence J. Thomas,L. Vitale,Michael Murphy,... - Cancer Research 被引量: 0发表: 2023年 Combining MARTE-UML, SysML and CVL to Bui...
December 19, 2024 · 7 min read · Angela Gabriel Pipeline Merck Axes Two Cancer Candidates After Disappointing Late-Stage Results December 17, 2024 · 2 min read · Tristan Manalac Complete response letters J&J’s FDA Bid for Subcutaneous Rybrevant F...
Society of Clinical Oncology (ASCO) Annual Meeting. Clinical data from these trials in patients with recurrent GBM demonstrated brain penetrance of BDTX-1535, as well as safety and tolerability data similar to what has been previously described for patients with non-small cell lung cancer (NSCLC)...
regulatory approval and commercialization of new products. Tonix does not undertake an obligation to update or revise any forward-looking statement. Investors should read the risk factors set forth in the Annual Report on Form 10-K for the year endedDecember 31, 2023, as filed ...
Insmed Incorporated (Nasdaq:INSM) today announced that eight presentations across three of its pillars—ARIKAYCE® (amikacin liposome inhalation suspension), brensocatib, and treprostinil palmitil inhalation powder (TPIP)...